Table 6.9. Threshold Radioactive Exposures and Recommended Prophylactic Single Doses of KI
| Patients by Age/Sex |
Predicted Thyroid
Exposure (Gy) |
KI Dose (mg) |
No. of 130-mg
tablets |
No. of 65-mg
tablets |
Adults
>40 yr old |
>5 |
130 |
1 |
2 |
Adults
18-40 yr |
>0.1 |
130 |
1 |
2 |
| Pregnant or lactating women |
>0.05 |
130 |
1 |
2 |
| Adolescents 12-18 yr old |
>0.05 |
130 |
1 |
2 |
Children
3-12 yr old |
>0.05 |
>65 |
1/2 |
1 |
Children
1 mo to 3 yr old |
>0.05 |
32 |
1/4 |
1/2 |
Neonates
birth to 1 mo old |
>0.05 |
16 |
1/8 |
1/4 |
Source: Adapted from U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies. Available at http://www.fda.gov/cder/guidance/4825fnl.htm.
Return to Document